SHR-3792
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SHR-3792, covering 2025-04-25 to 2025-04-25. Get the full timeline:
Most recent: Clinical Trial Update: A Trial of SHR-3792 Injection in Patients With Advanced Solid Tumors [Phase 1]